Cargando…

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment

PURPOSE: This study aimed to determine the pathological complete response (pCR), overall survival (OS), and disease-free survival (DFS) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) using post-neoadjuvant chemoradiotherapy (nCRT) F-18-fluorodeoxyglucose ((18)FDG). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Wei-Hsiang, Chen, Ying-Yi, Kuo, Yen‐Shou, Lin, Kuan-Hsun, Tsai, Yuan-Ming, Wu, Ti-Hui, Huang, Hsu-Kai, Huang, Tsai-Wang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284765/ https://www.ncbi.nlm.nih.gov/pubmed/35836202 http://dx.doi.org/10.1186/s12885-022-09852-2

Ejemplares similares

Role of FDG-PET/CT in prediction of pathological tumor response and survival after trimodality therapy for esophageal squamous cell carcinoma
por: Hamai, Yoichi, et al.
Publicado: (2015)

Prognostic Value of (18)F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma
por: Shen, Daniel Hueng-Yuan, et al.
Publicado: (2021)

FDG PET/CT and Endoscopic Ultrasound for Preoperative T-Staging of Esophageal Squamous Cell Carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2023)

The clinical application of 4D (18)F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer
por: Wang, Yao-Ching, et al.
Publicado: (2012)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
por: Decazes, Pierre, et al.
Publicado: (2021)

(18)F‐FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma
por: Wang, Shuohua, et al.
Publicado: (2023)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Integrating (18)F‐FDG PET/CT with lung dose‐volume for assessing lung inflammatory changes after arc‐based radiotherapy for esophageal cancer: A pilot study
por: Hsu, Chen‐Xiong, et al.
Publicado: (2022)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy
por: Hinault, Pauline, et al.
Publicado: (2022)

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma
por: CASTALDI, P., et al.
Publicado: (2013)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

Prognostic Significance of Pretreatment Staging With (18)F-FDG PET in Esophageal Cancer: A Nationwide Population-Based Study
por: Lu, Hsi-Huei, et al.
Publicado: (2021)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients
por: Soydal, Çiğdem, et al.
Publicado: (2014)

18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment
por: Krengli, Marco, et al.
Publicado: (2022)

Comparison of (18)F-FDG PET/CT imaging with different dual time (18)F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
por: Yu, Longhua, et al.
Publicado: (2023)

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2019)

Improved image resolution on thoracic carcinomas by quantitative (18)F-FDG coincidence SPECT/CT in comparison to (18)F-FDG PET/CT
por: Zheng, Yuming, et al.
Publicado: (2020)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma
por: Lin, Nan-Chin, et al.
Publicado: (2021)

Diagnostic Accuracy of Combined PET/CT with MRI, 18F-FDG PET/MRI, and 18F-FDG PET/CT in Patients with Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Kave, Mania, et al.
Publicado: (2021)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Modified method to improve the diagnostic efficiency of (18)F-FDG PET/CT in regional lymph node metastasis of esophageal squamous cell carcinoma
por: Liao, Siqin, et al.
Publicado: (2021)

Diffusion-weighted MRI and (18)F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2021)

Can (18)F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?
por: Jayaprakasam, Vetri Sudar, et al.
Publicado: (2022)

Application of (18)F-FDG PET/CT in Langerhans Cell Histiocytosis
por: Liao, Fengxiang, et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

(18)F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
por: Mantziari, Styliani, et al.
Publicado: (2020)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
por: Bayar, Melikşah, et al.
Publicado: (2021)

Identification of (18)F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer
por: Galvez, Thierry, et al.
Publicado: (2023)

Potential Usefulness of FDG PET/CT in Patients with Sepsis of Unknown Origin
por: Tseng, Jing-Ren, et al.
Publicado: (2013)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis
por: Yao, Lan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_imirjkqibge6e2dl6ckfa7nh3m